Advantage Sun Pharma As Tel Aviv Court Rules Out Special Tender Offer For Taro Shares

MUMBAI - Sun Pharmaceutical has emerged victorious in the protracted battle with Taro Pharmaceutical in its bid to acquire control of the Israel headquartered company. A Tel Aviv District Court rejected Taro's contention for a special tender offer under Israeli law before Sun Pharma could proceed with its objective to gain control of Taro management